TY - JOUR
T1 - Integrative Medicine for Pain Management in Oncology
T2 - Society for Integrative Oncology-ASCO Guideline
AU - Mao, Jun J.
AU - Ismaila, Nofisat
AU - Bao, Ting
AU - Barton, Debra
AU - Ben-Arye, Eran
AU - Garland, Eric L.
AU - Greenlee, Heather
AU - Leblanc, Thomas
AU - Lee, Richard T.
AU - Lopez, Ana Maria
AU - Loprinzi, Charles
AU - Lyman, Gary H.
AU - MacLeod, Jodi
AU - Master, Viraj A.
AU - Ramchandran, Kavitha
AU - Wagner, Lynne I.
AU - Walker, Eleanor M.
AU - Bruner, Deborah Watkins
AU - Witt, Claudia M.
AU - Bruera, Eduardo
N1 - Publisher Copyright:
© American Society of Clinical Oncology.
PY - 2022/12/1
Y1 - 2022/12/1
N2 - PURPOSEThe aim of this joint guideline is to provide evidence-based recommendations to practicing physicians and other health care providers on integrative approaches to managing pain in patients with cancer.METHODSThe Society for Integrative Oncology and ASCO convened an expert panel of integrative oncology, medical oncology, radiation oncology, surgical oncology, palliative oncology, social sciences, mind-body medicine, nursing, and patient advocacy representatives. The literature search included systematic reviews, meta-analyses, and randomized controlled trials published from 1990 through 2021. Outcomes of interest included pain intensity, symptom relief, and adverse events. Expert panel members used this evidence and informal consensus to develop evidence-based guideline recommendations.RESULTSThe literature search identified 227 relevant studies to inform the evidence base for this guideline.RECOMMENDATIONSAmong adult patients, acupuncture should be recommended for aromatase inhibitor-related joint pain. Acupuncture or reflexology or acupressure may be recommended for general cancer pain or musculoskeletal pain. Hypnosis may be recommended to patients who experience procedural pain. Massage may be recommended to patients experiencing pain during palliative or hospice care. These recommendations are based on an intermediate level of evidence, benefit outweighing risk, and with moderate strength of recommendation. The quality of evidence for other mind-body interventions or natural products for pain is either low or inconclusive. There is insufficient or inconclusive evidence to make recommendations for pediatric patients. More research is needed to better characterize the role of integrative medicine interventions in the care of patients with cancer.Additional information is available at https://integrativeonc.org/practice-guidelines/guidelines and www.asco.org/survivorship-guidelines.
AB - PURPOSEThe aim of this joint guideline is to provide evidence-based recommendations to practicing physicians and other health care providers on integrative approaches to managing pain in patients with cancer.METHODSThe Society for Integrative Oncology and ASCO convened an expert panel of integrative oncology, medical oncology, radiation oncology, surgical oncology, palliative oncology, social sciences, mind-body medicine, nursing, and patient advocacy representatives. The literature search included systematic reviews, meta-analyses, and randomized controlled trials published from 1990 through 2021. Outcomes of interest included pain intensity, symptom relief, and adverse events. Expert panel members used this evidence and informal consensus to develop evidence-based guideline recommendations.RESULTSThe literature search identified 227 relevant studies to inform the evidence base for this guideline.RECOMMENDATIONSAmong adult patients, acupuncture should be recommended for aromatase inhibitor-related joint pain. Acupuncture or reflexology or acupressure may be recommended for general cancer pain or musculoskeletal pain. Hypnosis may be recommended to patients who experience procedural pain. Massage may be recommended to patients experiencing pain during palliative or hospice care. These recommendations are based on an intermediate level of evidence, benefit outweighing risk, and with moderate strength of recommendation. The quality of evidence for other mind-body interventions or natural products for pain is either low or inconclusive. There is insufficient or inconclusive evidence to make recommendations for pediatric patients. More research is needed to better characterize the role of integrative medicine interventions in the care of patients with cancer.Additional information is available at https://integrativeonc.org/practice-guidelines/guidelines and www.asco.org/survivorship-guidelines.
UR - http://www.scopus.com/inward/record.url?scp=85142941172&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85142941172&partnerID=8YFLogxK
U2 - 10.1200/JCO.22.01357
DO - 10.1200/JCO.22.01357
M3 - Article
C2 - 36122322
AN - SCOPUS:85142941172
SN - 0732-183X
VL - 40
SP - 3998
EP - 4024
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
IS - 34
ER -